safingol has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bahlous, A; Ben Fayala, C; Boubaker, MS; Kharrat, R; Marrouchi, R; Marzougui, Z; Tounsi-Kettiti, H; Trabelsi, H | 1 |
| Allgood, JC; Dillehay, DL; Merrill, AH; Moody, SJ; Morales, PR; Pallas, DC; Pruett, S; Symolon, H | 1 |
| Bacon, CW; Chamberlain, WJ; Hinton, DM; Merrill, AH; Riley, RT; Voss, KA; Wang, E | 1 |
3 other study(ies) available for safingol and Kidney Diseases
| Article | Year |
|---|---|
Marine toxin C17-SAMT causes major structural damage to vital organs in mice following subchronic toxicity trials.
Topics: Animals; Kidney Diseases; Liver; Marine Toxins; Mice; Mycotoxins; Necrosis | 2023 |
Safingol toxicology after oral administration to TRAMP mice: demonstration of safingol uptake and metabolism by N-acylation and N-methylation.
Topics: Acylation; Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; BALB 3T3 Cells; Biotransformation; Body Weight; Cell Line, Tumor; Cell Survival; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Hematocrit; Humans; Kidney Diseases; Liver; Liver Diseases; Male; Methylation; Mice; Mice, Transgenic; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Spectrometry, Mass, Electrospray Ionization; Sphingosine; Tissue Distribution | 2007 |
Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.
Topics: Animals; Chemical and Drug Induced Liver Injury; Diet; Female; Fumonisins; Kidney; Kidney Diseases; Liver; Male; Microscopy, Electron; Mycotoxins; Rats; Rats, Sprague-Dawley; Sphingolipids; Sphingosine | 1994 |